⚠️
The Critical Problem
- • CDI is the #1 healthcare-associated infection in Long-Term Care facilities
- • Highest risk population: Patients 65+ on antibiotic therapy
- • CDI drives hospital transfers, financial penalties, staffing strain, and reputation damage
💡
Our Innovative Solution
- ➡ MEGGA MIX Oral IgY antibodies from eggs – food-based, safe, non-systemic protection
- ➡ Preventive, not therapeutic – neutralizes CDI components before they cause infection
- ➡ Classified as nutritional food / immune support – not a prescription drug, faster adoption
📊
Strategic Benefits for LTC Facilities
| Value Driver | Business Impact |
|---|---|
| Cost & Risk Reduction | Fewer hospital transfers, outbreaks, and preventable readmissions |
| Quality Ratings | Directly improves CMS Star Rating and accreditation compliance |
| Regulatory Alignment | Supports infection prevention & antibiotic stewardship mandates |
| Operational Efficiency | Reduces isolation protocols, staffing strain, and employee turnover |
| Revenue Opportunity | Billable as nutritional or immune support supplement |
| Competitive Advantage | Differentiates facility for families, hospitals, and referral networks |
🎯
Market Advantage
15,000+
Nursing Homes
1.4M residents in U.S.
50%
Annual Antibiotic Use
Among LTC residents
Zero
Direct Competition
No existing food-based CDI prevention
📍
Strategic Positioning
Not a drug
No prescription required
Not a supplement
No regulatory burden
A Targeted Immune Food
For infection protection